Former Johnson & Johnson Medical China President Xie Wenjian Joins Dazhou Medical as Chief Strategic Officer

"Siqi Circle" learned that on June 27, Xie Wenjian officially joined Dazhou Medical as a board member and Chief Market Strategist.

From multinational giants to local innovative enterprises, this star manager who has overseen medical businesses with annual revenues exceeding 1 billion USD, and legendary CEO, has once again returned to the core battlefield of the medical device industry.

Xie Wenjian

Xie Wenjian's resume is a benchmark for professional managers in China's medical industry. He joined Johnson & Johnson Medical in 2000, starting as the sales director for blood glucose meters in China. In just six years, he was promoted to president of Johnson & Johnson Medical China – becoming the "first localized chairman" in Johnson & Johnson's history.

Star Manager: The Golden Age of Johnson & Johnson Medical

During the period when Xie Wenjian was in charge of Johnson & Johnson Medical China, the company ushered in a golden phase of development in China.

Public information shows that, under his leadership, Johnson & Johnson Medical maintained an annual business growth rate of over 20%, developing the company into China's **largest medical and diagnostic equipment enterprise**.

By the time of their departure, Johnson & Johnson Medical China had more than 3,000 employees and an annual revenue exceeding the $1 billion mark.

Xie Wenjian's leadership style is renowned for its strategic vision and local insights. In 2009, he represented Johnson & Johnson Medical in launching an orthopedic surgery skills training program with West China Hospital of Sichuan University, introducing internationally standardized orthopedic surgical techniques into China's grassroots healthcare system. This initiative established a new model of cooperation between multinational medical enterprises and top Chinese hospitals to cultivate professional talent.

Cross-Boundary Challenge: Transformation from Medical to Daily Chemicals

In 2013, Xie Wenjian ushered in a major turning point in his career — crossing over to serve as the Chairman and CEO of Shanghai Jahwa.

This appointment caused a stir in the industry at the time. An investor who had been following the domestic chemical industry once frankly said, "The leap from medical to daily chemical is actually quite significant. Johnson & Johnson Medical often deals with corporate clients like hospitals, so there must be substantial differences in marketing approaches compared to the daily chemical industry."

Ge Jianqiu, then vice president of Shanghai Pharmaceutical Group, made an vivid analogy: "It's like Alibaba's major shareholders teaming up to drive away Jack Ma and hire Tang Jun to take over as chairman."

This cross-boundary experience, though ended with Xie Wenjian's resignation in 2016, provided him with valuable senior management experience in the fast-moving consumer goods (FMCG) industry, expanding his career territory to the consumer products sector.

Return to Healthcare: ConvaTec and a New Journey

In April 2019, Xie Wenjian returned to the medical industry as the Vice President and General Manager of ConvaTec North Asia, overseeing operations in China, Hong Kong, Macao, Taiwan, and South Korea, while joining the company's Asia-Pacific leadership team.

This term of service continued until October 2021, when Convatec Chief Operating Officer Bruno Pinheiro announced to all employees that Xie Wenjian had decided to retire and leave the company due to personal and family reasons.

After three years of silence, Xie Wenjian chose to join Dazhou Medical, returning to the core circle of the medical industry. According to public information, he holds a Bachelor's degree in Chemistry from Fudan University, a Master’s degree in Biochemistry from Boston University, an MBA from the University at Albany, State University of New York, and has completed the Advanced Management Program at Harvard University.

A solid scientific background combined with over 30 years of multinational corporate management experience makes him a rare复合型高层人才.

It is worth noting that,On the evening of September 18, 2015, Xie Wenjian was stabbed by an unidentified man in front of the company office building. This incident was extremely malicious, and the company reported it to the public security department that night.

According to a report by "Finance Network" at the time, citing analysis from insiders: As a classic case of state-owned enterprise reform in Shanghai, the assault on Xie Wenjian may have been caused by his relentless promotion of various reforms since taking office, which touched and even disrupted the interests of certain vested interest groups. This is a microcosm of the various conflicts of interest that arise during the marketization of state-owned enterprises.

Reference Article:

1. Siqi Club, China Region "Airdrops" New President, Former CEO Steps Down

2. Financial Network,Shanghai Jahwa Chairman Xie Wenjian Injured in Stabbing at Office Building Entrance